Neurodegenerative Diseases
A section of Brain Sciences (ISSN 2076-3425).
Section Information
Neurodegenerative Diseases is a Section of Brain Sciences (ISSN 2076-3425), which concerns itself with any pathological condition affecting neurons and supporting cells; however, these disorders represent many neurological conditions, e.g., Parkinson’s, exhibiting numerous pathological manifestations. The aim of this Section is to encourage and provide a forum for scientists to publish their experimental results and theoretical concepts in this important area of scientific as well as medical research. There is no restriction on the maximum length of papers. Mechanistically, electronic files reporting the extended details of computational, statistical, or experimental procedures, if unwieldy for presentation in the body of a manuscript, can be deposited as supplementary material.
Keywords
- neurodegeneration;
- proteinopathies;
- pathogenic factors;
- oxidative stress;
- bioenergetic deficiency;
- mitochondrial defects;
- neuronal dysfunction/death;
- Parkinson's Disease;
- Alzheimer’s Disease;
- AI as an intervention;
- molecular processes involved in neurodegeneration.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Cognitive Health in Individuals with Multiple Sclerosis (Deadline: 20 October 2024)
- Advances in Memory and Cognitive Decline Associated with Aging and Alzheimer's Disease (Deadline: 25 October 2024)
- Clinical Research on Parkinson’s Disease: Opportunities and Challenges (Deadline: 31 October 2024)
- Role of Inflammation, Oxidative Stress, and Metabolic Dysfunction in Neurodevelopmental and Neurodegenerative Diseases: Pharmacological Targets and Therapeutic Interventions (Deadline: 16 November 2024)
- Genetics of Neurodegenerative Diseases: Retrospect and Prospect (Deadline: 25 November 2024)
- Genetics of Parkinson's Disease: Discoveries and Therapeutics (Deadline: 30 November 2024)
- New Challenges in the Study of Cognitive Impairment in Parkinson’s Disease (Deadline: 30 November 2024)
- The Biomarkers, Symptoms, and Treatment of Multiple Sclerosis (Deadline: 30 November 2024)
- Using Neuroimaging to Explore the Alzheimer’s Disease and Related Dementia (AD/ADRD) (Deadline: 20 December 2024)
- New Approaches in the Exploration of Parkinson’s Disease (Deadline: 31 December 2024)
- Current Basic and Clinical Approaches in Neurodegenerative Diseases: Diagnostics and Therapeutics (Deadline: 18 January 2025)
- Alpha-Synuclein in Neurodegenerative Disorders: From Pathogenesis to Potential Therapies (Deadline: 1 February 2025)
- Research Progress on the Pathogenesis, Diagnosis and Treatment of Parkinson Disease (Deadline: 1 February 2025)
- Frontotemporal Dementia: Behavioural and Neuroimaging Studies (Deadline: 28 February 2025)
- Molecular and Neuroimaging Biomarkers in Alzheimer’s Disease and Frontotemporal Lobar Degeneration (Deadline: 10 March 2025)
- Focusing on the Rhythmic Interventions in Movement Disorders (Deadline: 21 March 2025)
- Reading, Spelling, and Visual Functions in Patients with Posterior Cortical Atrophy (Deadline: 1 April 2025)
- Advances in Biomedical Research and Clinical Studies of Parkinson’s Disease and Atypical Parkinsonian Disorders (Deadline: 25 July 2025)
Topical Collection
Following topical collection within this section is currently open for submissions:
